There are few phrases in the junior markets more dangerous than “in the coming weeks.” “In the coming months” is another good one. “Soon enter the market” should probably…
Health Science
There are investment pitches that require you to understand geology, biotechnology, or semiconductor architecture. And then there are investment pitches where the first question is, “Hang on. You want to…
Back in 2018, I wrote often about a medtech company called Vitalhub (VHI.T). Essentially, they were at the starting point of what we now know as TELE-MEDICINE. Here’s me,…
BioNxt Solutions (CSE: BNXT) received a share price boost today after announcing the European Patent Office and its Eurasian counterpart have waved through core claims tied to the company’s…
I see a lot of company pitches in my job. I also see a lot of AI pitches. I don’t see a lot of good ones of each. Last…
Hemostenix (HEM.V) has been lifting off of late, and as we’ve seen some real upward movement in the pharmaceuticals/biotech space in Canada of late (See Onco Innovations and Voyageur…
This past month I’ve had three conversations with friends that included the following sentences. “It’s been two years but something doesn’t feel right, I’m going in next week.” “I’m…
Quite often, when I talk to mining explorers, I’m left to wonder why their focus is so often on digging things out of the ground and selling the raw…
Light AI’s claim: That it can revolutionize health diagnostics with your smartphone Imagine a world where diagnosing illnesses is as easy as snapping a picture of yourself with your…
As the world increasingly faces the complexities of autoimmune and neurodegenerative diseases, new medical advancements are crucial to better serve patients’ needs. Enter Bionxt Solutions Inc. (BNXT.C), a bioscience…